Ligand Pharmaceuticals Inc (LGND)

Capital Expenditure

-$278.00K

TTM · Period ending: · USD

LGND logo

LGND Capital Expenditure

Latest reported-$278.00K
LGND TTM CapEx (-$600.00K → -$278.00K)
High-resolution chart · PNG

LGND capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-1,570,000
-1,621,000
-1,085,000
-38,437,000
-38,855,000
-39,327,000
-39,500,000
-3,400,000
-2,600,000
-2,100,000
-2,400,000
-1,700,000
-2,100,000
-5,000,000
-4,300,000
-3,600,000
-3,600,000
-100,000
-400,000
-500,000
-600,000
-1,000,000
-700,000
-700,000
-600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.